Drug discovery today is fast-paced, cross-disciplinary, inter-connected and fueled by collaboration and creativity. Discovery on Target, has stayed true to its mission of keeping drug discovery efforts on target by highlighting the transformative scientific and technological advancements. It has showcased both current and emerging drug targets, modalities and technologies, from small molecules to antibodies. This year we will be adding peptides, conjugated therapies and radioligands to the coverage of topics. The four-day event, with 7 concurrent conference streams will cover innovations in small molecule target discovery, drug modalities, lead generation strategies, screening technologies, AI/machine learning, and recent developments in antibodies, conjugates and radioligand therapies.
The true impact of the event, however, lies in bringing together people involved in all aspects of drug discovery to listen, share and learn. The numerous concurrent sessions, insightful presentations, vibrant discussions, in-depth training seminars, practical short courses and interactive breakout discussions led by experts in the field are all designed to provide an opportunity to connect, network and collaborate.
Drug discovery is not a solo endeavor but built on knowledge-sharing and teamwork. Don’t miss out on this opportunity to stay at the forefront of drug discovery. Mark your calendar and come join us September 28-October 1, 2026, in Boston!
